Hence, the data indicates that Eupafolin inhibits growth and development of breast cancer cells by modulating the PI3K/Akt, MAPKs and NF-κB signaling pathway, which can be partially mediated by downregulated Cav-1 expression. Here, AKT1 is linked to breast cancer.